Perrigo Infant Formula Unit Wins Appellate Judgment
Allegan-based Perrigo Co. (Nasdaq: PRGO) Thursday announced that the United States Fourth Circuit Court of Appeals has affirmed an earlier decision that Mead Johnson had engaged in false advertising resulting in an injunction prohibiting Mead Johnson from making similar claims and awarding damages in favor of Perrigo’s PBM business unit.
Said Perrigo chairman and CEO Joseph C. Papa: “The court has made it clear that national brand and store brand suppliers are entitled to fairly compete and advertising abuses will not be tolerated. We also appreciate the court’s recognition that PBM could lawfully compare its products to national brand products.”
Perrigo develops, manufactures and distributes OTC and generic prescription pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients and pharmaceutical and medical diagnostic products. Perrigo is the world’s largest store brand manufacturer of OTC pharmaceutical products and infant formulas. The company’s primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia.
More at www.perrigo.com.